Surmodics | SRDX - Interest Expense On Debt


Surmodics reported $884K in Interest Expense on Debt for its fiscal quarter ending in September of 2024.





Interest Expense On Debt Change Date
Abbott USD 42M 2M Dec/2025
Align Technology USD 2M 660K Mar/2023
Anika Therapeutics 189.44M 1.76M Sep/2025
Arrowhead Research USD 22.5M 811K Dec/2025
Artivion USD 7.83M 1.22M Mar/2024
Baxter International USD 58M 14M Sep/2025
Boston Scientific USD 90M 3M Dec/2025
EDAP TMS EUR 49K 8K Sep/2025
Edwards Lifesciences USD 38.6M 1.2M Sep/2025
Haemonetics USD 7.21M 3.14M Sep/2025
Heron Therapeutics USD 500K 900K Sep/2024
J&J USD 18M 290M Sep/2025
Merit Medical Systems USD 6.36M 390K Dec/2025
Mesa Laboratories USD 3.02M 180K Sep/2024
Nektar Therapeutics USD 6.02M 420K Sep/2024
Option Care Health USD 12.73M 1.41M Dec/2025
Stryker USD 157M 46.17B Sep/2025
Surmodics USD 884K 5K Sep/2024
Trinity Biotech USD 3.33M 50K Sep/2025